Accueil>>Signaling Pathways>> Cell Cycle/Checkpoint>> Proteolysis>>Z-Phe-Tyr(tBu)-diazomethylketone

Z-Phe-Tyr(tBu)-diazomethylketone (Synonyms: Cbz-Phe-Tyr(O-t-Bu)-CHN2, Z-Phe-Tyr(tBu)-CHN2)

Catalog No.GC45599

 

Products are for research use only. Not for human use. We do not sell to patients.

Z-Phe-Tyr(tBu)-diazomethylketone Chemical Structure

Cas No.: 114014-15-2

Taille Prix Stock Qté
1mg
52,00 $US
En stock
5mg
194,00 $US
En stock
10mg
361,00 $US
En stock
25mg
836,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Z-Phe-Tyr(tBu)-diazomethylketone is an inhibitor of cathepsin L (Kinact = 200,000 M-1s-1).1,2 It is selective for cathepsin L over cathepsin S and cathepsin B (Kinacts = 30 and 10.3 M-1s-1, respectively). Z-Phe-Tyr(tBu)-diazomethylketone is active against bloodstream forms of T. brucei brucei clone 427-221a in vitro (EC50 = 126 μM).3

References
1. Shaw, E., Mohanty, S., Colic, A., et al. The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain. FEBS Lett. 334(3), 340-342 (1993).
2. Kirschke, H., Wikstrom, P., and Shaw, E. Active center differences between cathepsins L and B: The S1 binding region. FEBS Lett. 228(1), 128-130 (1988).
3. Nkemngu, N.J., Grande, R., Hansell, E., et al. Improved trypanocidal activities of cathepsin L inhibitors. Int. J. Antimicrob. Agents 22(2), 155-159 (2003).

Avis

Review for Z-Phe-Tyr(tBu)-diazomethylketone

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Z-Phe-Tyr(tBu)-diazomethylketone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.